BRIEF-AstraZeneca Provides Update on Evusheld US EUA

Reuters | Updated: 27-01-2023 00:05 IST | Created: 26-01-2023 23:56 IST
BRIEF-AstraZeneca Provides Update on Evusheld US EUA
Representative Image Image Credit: Flickr

AstraZeneca PLC: * UPDATE ON EVUSHELD US EUA

* TO CONTINUE TO WORK WITH FDA, OTHER HEALTH AUTHORITIES TO COLLECT, ASSESS, SHARE RELEVANT DATA REGARDING EVUSHELD AND SARS-COV-2 VARIANTS * EVUSHELD REMAINS AUTHORISED IN OTHER COUNTRIES WHERE IT IS APPROVED FOR COVID PRE-EXPOSURE PROPHYLAXIS,TREATMENT, INCLUDING EU AND JAPAN Source text for Eikon: Further company coverage:

TRENDING

1
End of an Era: Steve Clarke Steps Down as Scotland's Iconic Head Coach

End of an Era: Steve Clarke Steps Down as Scotland's Iconic Head Coach

Global
2
Australia Doubles Down on Social Media Age Ban Enforcement

Australia Doubles Down on Social Media Age Ban Enforcement

Global
3
Steve Clarke Steps Down After Scotland's World Cup Elimination

Steve Clarke Steps Down After Scotland's World Cup Elimination

Global
4
Steve Clarke Steps Down After Historic Run as Scotland's Head Coach

Steve Clarke Steps Down After Historic Run as Scotland's Head Coach

Global

PERSPECTIVES AND INSIGHTS

Can Rural Policy Deliver the SDGs, or Just Promise Them?

Ethiopia’s HIV Progress Has a Co-Infection Blind Spot

Schools Are Rushing Into AI: Here’s What They’re Missing

Can Strong Governance Shield Africa from the Social Costs of Global Volatility?

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.

Subscribe to our Newsletter  

STANDARDS & POLICIES

EDITIONS

OTHER LINKS

CONNECT

Devdiscourse
Disclaimer | Terms of use | Privacy Policy

© Copyright 2026